APR 1301-01 PKU – Genetic Metabolic Disease
2014-10-14T21:28:27+00:00
- About Us
- APR Products
- Prescription Healthcare Products
- Consumer Healthcare Products
- Therapeutical Areas
- Pipeline
- Our Services
- Media
- Contact
Discover who we are and our partners global network, as well as learn more about our people.
Learn more about our products and how they provide innovative solutions for patiens' unmet needs.
Discover our capabilities in project design services.
Find information such as website news, press releases and event presentations.
Get in touch with us to set up a meeting or propose your cooperation.
Introducing APR 1301-01.
A revolutionary innovation to face PKU challenges.
A brand new generation of medical food is coming. A prolonged release formulation with the aim to allow the physiological absorption of Amino Acids. Odor, taste and aftertaste friendly.
APR 1301-01 is an advanced formulation of Amino Acids, enriched with vitamins and minerals, with the potential of contributing to better control of Phenylalanine metabolism in PKU patients.
Thanks to APR healthcare company's innovative Physiomimic™ patented technology, it allows to obtain a revolutionary formulation in coated micro granules engineered to permit a prolonged Amino Acid release.
A prolonged release sustains a physiological Amino Acid absorption.
The applied innovative Physiomimic™ technology results in full masking of the unpleasant taste and odor of free Amino Acid formulations and, as a consequence, may eliminate the typical unwanted aftertaste effect.
